Philip Jochelson

This inventor holds 19 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents. Top assignees: Currax Pharmaceuticals LLC, Pernix Sleep, Inc., Procom One, Inc.. Active years: 2011-2024.

USPTO Granted Patents = 19 (Patent Applications = 13)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 35(Granted Patents)

Company Filing History:

9 out of 13

Currax Pharmaceuticals LLC

Somaxon Pharmaceuticals, Inc.

patent

where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12083090 - Methods of using low-dose doxepin for the improvement of sleep (2024-09-10),

2. 11234954 - Low-dose doxepin for treatment of sleep disorders in elderly patients (2022-02-01),

3. 11110074 - Methods of improving the pharmacokinetics of doxepin (2021-09-07),

4. 11096920 - Low-dose doxepin formulations and methods of making and using the same (2021-08-24),

5. 11013712 - Methods of treating insomnia using a combination therapy of low-dose doxepin and zolpidem (2021-05-25),

6. 10653662 - Methods of using low-dose doxepin for the improvement of sleep (2020-05-19),

7. 10653660 - Methods of improving the pharmacokinetics of doxepin (2020-05-19),

8. 10548871 - Low-dose doxepin formulations and methods of making and using the same (2020-02-04),

9. 10507193 - Ultra low dose doxepin and methods of using the same to treat sleep disorders (2019-12-17),

10. 10238620 - Methods of using low-dose doxepin for the improvement of sleep (2019-03-26),

11. 9907780 - Low-dose doxepin formulations and methods of making and using the same (2018-03-06),

12. 9907779 - Ultra low dose doxepin and methods of using the same to treat sleep disorders (2018-03-06),

13. 9861607 - Methods of using low-dose doxepin for the improvement of sleep (2018-01-09),

14. 9572814 - Methods of improving the pharmacokinetics of doxepin (2017-02-21),

15. 9532971 - Low-dose doxepin formulations and methods of making and using the same (2017-01-03),

Title: Innovations in Sleep Medicine: The Contributions of Philip Jochelson

Introduction: Philip Jochelson, based in San Diego, California, is a notable inventor in the field of sleep medicine, boasting an impressive portfolio of 19 patents. His work primarily focuses on methods for improving sleep quality, particularly through the use of low-dose doxepin, a medication that has shown significant promise in treating sleep disorders.

Latest Patents: Jochelson's latest patents include innovative methods for utilizing low-dose doxepin to enhance sleep efficacy. One of his remarkable patents details methods of preventing early awakenings and improving sleep efficiency during the crucial hours of 7 and 8 of sleep by administering low doses, specifically between 1-6 mg. Another notable invention addresses the unique challenges faced by elderly patients, specifically those aged 65 and older. His research indicates that administering initial daily dosages of doxepin ranging from 1-3 mg can effectively treat insomnia and related sleep disorders. These ultra-low dosages have been found to significantly decrease wake time during sleep and improve the overall sleep cycle, especially in the last hour of an 8-hour sleep duration, while ensuring safety for elderly individuals.

Career Highlights: Throughout his career, Philip Jochelson has made impactful contributions to the pharmaceutical sector by working with prestigious companies such as Pernix Sleep, Inc. and Currax Pharmaceuticals LLC. His dedication to developing effective solutions for sleep disorders has not only advanced the field of sleep medicine but has also enhanced the quality of life for many individuals suffering from these conditions.

Collaborations: Jochelson has collaborated with esteemed colleagues such as Roberta L. Rogowski and Susan E. Dubé. Together, they have worked on various projects aimed at refining treatment methodologies for sleep disorders, thereby furthering innovations in this critical area of health.

Conclusion: Philip Jochelson's contributions to the field of sleep medicine through his innovative patents and collaborative efforts exemplify the importance of research and development in addressing common health issues. His work continues to pave the way for more effective treatments for sleep disorders, especially among the elderly, ensuring that better sleep health is within reach for many.